Enzo Biochem, Inc. is focused on molecular diagnostics and has a portfolio of technical platforms and reagent sets supporting a diverse range of biomedical research and translational science needs. Co. operates through the product segment, which manufactures, develops and markets products and tools for clinical research, translational research, drug development and bioscience research customers worldwide. Co. is engaged in product development and manufactures and supplies a comprehensive portfolio of products, including antibodies, genomic probes, assays, biochemicals and proteins. We show 65 historical shares outstanding datapoints in our coverage of ENZ's shares outstanding history.
Understanding the changing numbers of ENZ shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like ENZ versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching ENZ by allowing them to research ENZ shares outstanding history
as well as any other stock in our coverage universe. |
Free ENZ Email Alerts:
Video: Shares Outstanding Importance
